3D model of human placenta developed
MedUni Vienna researchers have now successfully developed a 3D model of the human placenta. The 3D "in vitro" model of the early human placenta was produced in a collaborative project involving the research groups of Martin Knöfler from MedUni Vienna's Department of Obstetrics and Gynecology (Division of Obstetrics and Gynaecology) and Paulina Latos from MedUni Vienna's Center for Anatomy and Cell Biology.
First organoid model of the placenta – based on other tissue culture models
"Over the last few years, 3D tissue culture models, called organoids, have rapidly been established for many different human organs. In most cases, these organoids consist of only a few cell types from the respective tissue and therefore have a simpler structure than the original organ," explain the researchers. Working on this basis, the team from the Medical University of Vienna managed to develop an organoid model of the placenta, consisting of the prevailing placental cell population, so-called trophoblasts.
Knöfler and Latos explain: "As a puretrophoblast organoid without blood vessels or connective tissue components, this model mirrors the trophoblast-specific placental structure in a Petri dish." This was done by optimising the culture conditions that had already been successfully applied in organoid models of other tissues.
A significant advantage of the placenta organoids is their capacity for self-organisation, self-renewal and constant growth, stress the MedUni Vienna scientists, since they contain both stem cells and progenitors. Moreover, these 3D structures also contain the three main cell types of the human trophoblast population.
The MedUni Vienna researchers were able to underpin the groundbreaking advantages of this organoid system with a study substantiating the role of the WNT signaling pathway (which is crucial for development and growth of many tissues) in self-renewal and differentiation of the trophoblast organoids. The organoid model system can also be pharmacologically and genetically manipulated. This opens up new possibilities for studying physiological and pathophysiological processes of the human placenta.
"The fact that there were no self-renewing cell culture model systems available for the human placenta made it difficult, if not impossible, to study the causes of malfunctions. Establishment of the placenta organoid system will improve this situation significantly and will help advancing drug development and consequently medical treatments for dangerous gestational disorders," emphasises Knöfler, one of the leading international experts in placental research and last author of the study.
Original publication
“Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta”; Sandra Haider, Gudrun Meinhardt, Leila Saleh, Viktoria Kunihs, Magdalena Gamperl, Ulrich Kaindl, Adolf Ellinger, Thomas R. Burkard, Christian Fiala, Jürgen Pollheimer, Sasha Mendjan, Paulina A. Latos and Martin Knöfler; Stem Cell Reports; 2018
Original publication
“Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta”; Sandra Haider, Gudrun Meinhardt, Leila Saleh, Viktoria Kunihs, Magdalena Gamperl, Ulrich Kaindl, Adolf Ellinger, Thomas R. Burkard, Christian Fiala, Jürgen Pollheimer, Sasha Mendjan, Paulina A. Latos and Martin Knöfler; Stem Cell Reports; 2018
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.